Everolimus-induced activation of latent Mycobacterium tuberculosis infection in a patient with metastatic renal cell carcinoma

Korean J Intern Med. 2017 Mar;32(2):365-368. doi: 10.3904/kjim.2015.121. Epub 2016 Feb 2.

Authors

So-Yeon Jeon¹, Ho-Young Yhim^{1

2}, Na-Ri Lee^{1

2}, Eun-Kee Song^{1

2}, Jae-Yong Kwak^{1

2}, Chang-Yeol Yim^{1

2}

Affiliations

¹ Division of Hematology/Oncology, Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea.
² Research Institute of Clinical Medicine, Chonbuk National University Hospital, Jeonju, Korea.

No abstract available

Keywords: Everolimus; Latent tuberculosis infection reactivation; Metastatic renal cell carcinoma.

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / adverse effects*
Antitubercular Agents / therapeutic use
Carcinoma, Renal Cell / drug therapy*
Carcinoma, Renal Cell / secondary
Drug Substitution
Drug Therapy, Combination
Everolimus / adverse effects*
Humans
Immunocompromised Host
Kidney Neoplasms / drug therapy*
Kidney Neoplasms / pathology
Latent Tuberculosis / chemically induced*
Latent Tuberculosis / drug therapy
Latent Tuberculosis / immunology
Latent Tuberculosis / microbiology
Male
Middle Aged
Mycobacterium tuberculosis / drug effects
Mycobacterium tuberculosis / pathogenicity*
Opportunistic Infections / chemically induced*
Opportunistic Infections / drug therapy
Opportunistic Infections / immunology
Opportunistic Infections / microbiology
Tomography, X-Ray Computed
Treatment Outcome

Substances

Antineoplastic Agents
Antitubercular Agents
Everolimus